Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
325.00    -8.00 (-2.40%)
Bid:
320.00
Ask:
330.00
Spread: 10.00 (3.125%)
Market Cap: £41.24m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Trading Update

14 Jan 2011 08:02

RNS Number : 4753Z
BrainJuicer Group PLC
14 January 2011
Β 

ο»Ώ

Β 

Β 

Β 

Press Release 14 January 2011

Β 

Β 

BrainJuicer Group PLC

Β ("BrainJuicer" and the "Company")

Β 

Trading Update

Β 

BrainJuicer, the innovative, international online market research agency, has today released the following update on trading during its financial year ended 31 December 2010. The Company's final results will be announced on 24 March 2011.

Β 

Trading during the seasonally important final quarter of the year was good, and for the year as a whole revenue increased by more than 35%, to over Β£16m. Profits have also grown well, and the Company expects operating profit for the year to somewhat exceed market expectations. BrainJuicer continued to invest heavily in support of future growth, and yet cash generation was again strong: period end cash was over Β£2.5m, up from Β£1.6m at end June, with no debt.

Β 

Growth in 2010 was driven primarily by the Company's operations in the US and UK, as clients, especially multi-nationals, continued to adopt its innovative research methods. Our businesses in Switzerland and Germany both made good progress in only their second full year of operation. During the year BrainJuicer opened offices in Brazil and China to enhance its geographic coverage and we are optimistic about our prospects in these strategically important markets.

Β 

The Company has continued to build its reputation and credibility within the industry, winning Marketing Magazine's Research Agency of the Year 2010, Best Paper Award from the Market Research Society, Young Researcher of the Year (to one of our employees) from ESOMAR, and Best Place to Work from Research Magazine.

Β 

Β 

- Ends -

Β 

Β 

For further information, please contact:

Β 

BrainJuicer Group PLC

John Kearon, Chief Executive Officer Tel: +44 (0)20 7043 1000

James Geddes, Chief Financial Officer www.brainjuicer.com

Β 

Canaccord Genuity Limited

Mark Williams / Henry Fitzgerald-O'Connor Tel: +44 (0)20 7050 6500

www.canaccordgenuity.com

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTUSRWRARAAARR
Date   Source Headline
1st May 20264:30 pmRNSHolding(s) in Company
21st Apr 20267:01 amRNSRelationship Agreement with Brave Bison
21st Apr 20267:00 amRNSQ4 and Full Year Trading Update
9th Apr 20267:00 amRNS-RLaunch of next evolution of Test Your Ad platform
30th Mar 20264:30 pmRNSHolding(s) in Company
30th Mar 20263:30 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSTrading Update
16th Mar 20267:00 amRNSTrading Update
5th Mar 20263:15 pmRNSDirector/PDMR Shareholding
3rd Mar 20265:15 pmRNSHolding(s) in Company
3rd Mar 20264:06 pmRNSBoard Change
2nd Mar 20261:39 pmRNSShareholder update & PDMR Dealing
2nd Mar 20267:00 amRNSDirectorate change
30th Jan 20261:00 pmRNSBoard Committee and Change of Role Update
20th Jan 20267:00 amRNSTrading Update
12th Jan 20264:45 pmRNSAppointment of Joint Corporate Broker
2nd Dec 20257:00 amRNSInterim Results
20th Nov 202511:45 amRNSHolding(s) in Company
24th Oct 20253:28 pmRNSHolding(s) in Company
22nd Oct 20257:00 amRNSTrading Update
14th Oct 20259:16 amRNSCapital Markets Day
6th Oct 20253:30 pmRNSDirector/PDMR Shareholding
30th Sep 20257:00 amRNSDirector/PDMR Shareholding - replacement
29th Sep 20255:48 pmRNSDirector/PDMR Shareholding
29th Sep 20251:27 pmRNSHolding(s) in Company
26th Sep 20252:29 pmRNSHolding(s) in Company
26th Sep 20257:00 amRNSDirector/PDMR Shareholding
24th Sep 20253:01 pmRNSResult of AGM
23rd Sep 20257:00 amRNSTrading Update
15th Sep 20251:00 pmRNSDirector/PDMR Shareholding
27th Aug 20254:51 pmRNSNotice of AGM
8th Aug 20254:35 pmRNSDirector/PDMR Shareholding
9th Jul 20257:00 amRNSDirector Role Change
9th Jul 20257:00 amRNSFinal Results
9th Jul 20257:00 amRNSTrading Update
4th Jul 202511:45 amRNSHolding(s) in Company
4th Jul 20257:00 amRNSHolding(s) in Company
16th Jun 20251:30 pmRNSHolding(s) in Company
14th May 20257:00 amRNSEstablishment of New Long-Term Incentive Plan
24th Apr 20251:53 pmRNSHolding(s) in Company
23rd Apr 20257:00 amRNSTrading Statement
23rd Jan 20257:00 amRNSHolding(s) in Company
21st Jan 20257:00 amRNSTrading Update
8th Jan 202510:15 amRNSHolding(s) in Company
3rd Dec 20247:00 amRNSInterim Results
28th Nov 20247:00 amRNSInterim Results Presentation
21st Nov 20243:31 pmRNSHolding(s) in Company
28th Oct 202410:15 amRNSDirector/PDMR Shareholding
23rd Oct 20247:00 amRNSDirector/PDMR Shareholding
22nd Oct 20247:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.